Preparation and characterization of HA–PEG–PCL intelligent core–corona nanoparticles for delivery of doxorubicin

References

• Akima K, Ho H, Iwata Y, Matsuo K, Watari N, Yanagi M, Hagi H, Oshima K, Yagita A, Atomi Y, Tatekawa I. Evaluation of antitumor activities of hyaluronate binding antitumor drugs: Synthesis, characterization and antitumor activity. J Drug Target 1996; 4: 1–8
   PubMed Web of Science ®Google Scholar
• Allemann E, Gurny R, Doelker E. Drug–loaded nanoparticles preparation method and drug targeting tissues. Eur J Pharm Biopharm 1993; 39: 173–191
   Web of Science ®Google Scholar
• Anghileri LJ. In vivo synthesis of acid mucopolysaccharides by Ehrlich ascites tumor cells. Z Krebsforsch Klin Onkol Cancer Res Clin Oncol 1976; 88: 17–24
   PubMedGoogle Scholar
• Bodmeier R, Oh KH, Chen H. The effect of the addition of low molecular weight poly (d, l-lactide) on drug release from biodegradable poly(d, l-lactide) drug release systems. Int J Pharm 1989; 51: 1–8
   Web of Science ®Google Scholar
• Cavallaro G, Mariano L, Salmaso S, Caliceti P, Gaetano G. Folate mediated targeting of polymeric conjugates of gemcitabine. Int J Pharm 2006; 307: 258–269
   PubMed Web of Science ®Google Scholar
• Cera C, Palumbo M, Stefanelli S, Rassu M, Palu G. Water-soluble polysaccharide–anthracycline conjugates: Biological activity. Anticancer Drug Des 1992; 7: 143–151
   PubMedGoogle Scholar
• Chorny M, Fishbein I, Danenberg HD, Golomb G. Lipophilic drug loaded nanospheres by nanoprecipitation: Effect of formulation variables on size, drug recovery and release kinetics. J Control Rel 2002; 83: 389–400
   PubMed Web of Science ®Google Scholar
• Cho KY, Chung TW, Kim BC, Kim MK, Lee JH, Wee WR, Cho CS. Release of ciprofloxacin from poloxamer-graft-hyaluronic acid hydrogels in vitro. Int J Pharm 2003; 260: 83–91
   PubMed Web of Science ®Google Scholar
• Coradini D, Pellizzaro C, Miglierini G, Daidone MG, Perbellini A. Hyaluronic acid as drug delivery for sodium butyrate: Improvement of the anti-proliferative activity on a breast-cancer cell line. Int J Cancer 1999; 81: 411–416
   PubMed Web of Science ®Google Scholar
• Culty M, Nguyen HA, Underhillm CB. The hyaluronan receptor (CD44) participates in the uptake and degradation of hyaluronan. J Cell Biol 1992; 116: 1055–1062
   PubMed Web of Science ®Google Scholar
• Dong Y, Feng SS. Methoxy poly (ethylene glycol)–poly (lactide) (MPEG–PLA) nanoparticles for controlled delivery of anticancer drugs. Biomaterials 2004; 25: 2843–2849
   PubMed Web of Science ®Google Scholar
• Fransson LA. Mammalian polysaccharides. The polysaccharides, O Aspinall. Academic Press, New York 1985; Vol. 3: 347–348
   Google Scholar
• Gref R, Couvreur P, Barratt G, Mysiakine E. Surface-engineered nanoparticles for multiple ligand coupling. Biomaterials 2003; 24: 4529–4537
   PubMed Web of Science ®Google Scholar
• Hall CL, Yang BH, Yang XW, Zhang SW, Turley M, Samuel S, Lange LA, Wang C, Curpen GD, Savani RC, Greenberg AH, Turley EA. Overexpression of the hyaluronan receptor RHAMM is transforming and is also required for h-ras transformation. Cell 1995; 82: 19–28
   PubMed Web of Science ®Google Scholar
• Jeon H, Jeong Y, Jang M, Park Y, Nah J. Effect of solvent on the preparation of surfactant-free poly (d, l-lactide-co-glycolide) nanoparticles and norfloxacin release characteristics. Int J Pharm 2000; 207: 99–108
   PubMed Web of Science ®Google Scholar
• Kim SY, Lee YM. Taxol-loaded block copolymer nanospheres composed of methoxy poly (ethylene glycol) and poly (ε-caprolactone) as novel anticancer drug carriers. Biomaterials 2001; 22: 1697–1704
   PubMed Web of Science ®Google Scholar
• Laurent TC. Structure of hyaluronic acid. Chemistry and molecular biology of the intercellular matrix, EA Balazs. Academic Press, New York 1970; 703–721
   Google Scholar
• Luo Y, Prestwich GD. Synthesis and selective cytotoxicity of a hyaluronic acid–antitumor bioconjugate. Bioconjug Chem 1999; 10: 755–763
   PubMed Web of Science ®Google Scholar
• Luo Y, Kirker KR, Prestwich GD. Cross-linked hyaluronic acid hydrogel films: New biomaterials for drug delivery. J Control Rel 2000; 69: 169–184
   PubMed Web of Science ®Google Scholar
• Missirlis D, Kawamura R, Tirelli N, Hubbell JA. Doxorubicin encapsulation and diffusional release from stable, polymeric, hydrogel nanoparticles. Eur J Pharm Sci 2006; 29: 120–129
   PubMed Web of Science ®Google Scholar
• Mo Y, Lim LY. Paclitaxel-loaded PLGA nanoparticles: Potentiation of anticancer activity by surface conjugation with wheat germ agglutinin. J Control Rel 2005; 108: 244–262
   PubMed Web of Science ®Google Scholar
• Park EK, Lee SB, Lee YM. Preparation and characterization of methoxy poly(ethylene glycol)/poly (ε-caprolactone) amphiphilic block copolymeric nanospheres for tumor-specific folate-mediated targeting of anticancer drugs. Biomaterials 2005; 26: 1053–1061
   PubMed Web of Science ®Google Scholar
• Park K, Lee GY, Kim YS, Yu M, Park RW, Kim IS, Kim SY, Byun Y. Heparin–deoxycholic acid chemical conjugate as an anticancer drug carrier and its antitumor activity. J Control Rel 2006; 114: 300–306
   PubMed Web of Science ®Google Scholar
• Paul M, Laatiris A, Fessi H, Dufeu B, Durand B, Deniau M, Astier A. Pentamidine-loaded poly (d, l-lactide) nanoparticles: Adsorption and drug release. Drug Dev Res 1998; 43: 98–104
   Web of Science ®Google Scholar
• Peracchia MT, Gref R, Minamitake Y, Domb A, Lotan N, Langer R. PEG-coated nanospheres from amphiphilic diblock and multiblock copolymers: Investigation of their drug encapsulation and release characteristics. J Control Rel 1997; 46: 223–231
   Web of Science ®Google Scholar
• Reddy LH, Sharma RK, Murthy RSR. Enhanced tumour uptake of doxorubicin B loaded poly (butyl cynoacrylate) nanoparticles in mice bearing dalton's lymphoma tumors. J Drug Target 2004; 2: 443–451
   Google Scholar
• Reddy LH, Sharma RK, Chuttani K, Mishra AK, Murthy RSR. Influence of administration route on tumor uptake and biodistribution of etoposide loaded solid lipid nanoparticles in dalton's lymphoma tumor bearing mice. J Control Rel 2005; 105: 185–198
   PubMed Web of Science ®Google Scholar
• Rooney P, Kumar S, Ponting J, Wang M. The role of hyaluronan in tumour neovascularization (review). Int J Cancer 1995; 60: 632–636
   PubMed Web of Science ®Google Scholar
• Ryu JG, Jeong YI, Kim YH, Kim IS, Kim DH, Kim SH. Preparation of core-shell type nanoparticles of poly (ε-caprolactone)/poly (ethylene glycol)/poly (ε-caprolactone) triblock copolymers. Bull Korean Chem Soc 2001; 22: 467–475
   Web of Science ®Google Scholar
• Scott JE, Cummings C, Brass AY, Chen Y. Secondary and tertiary structures of hyaluronan in aqueous solution, investigated by rotary shadowing-electron microscopy and computer stimulation. Biochem J 1991; 274: 699–705
   PubMed Web of Science ®Google Scholar
• Shuai X, Ai H, Nasongkla N, Kim S, Gao J. Micellar carriers based on block copolymers of poly (ε-caprolactone) and poly (ethylene glycol) for doxorubicin delivery. J Control Rel 2004; 98: 415–426
   PubMed Web of Science ®Google Scholar
• Thakkar H, Sharma RK, Mishra AK, Chuttani K, Murthy RSR. Efficiency of chitosan microspheres for controlled intra-articular delivery of celecoxib in inflammed joints. J Pharm Pharmcol 2004; 56: 1091–1099
   PubMed Web of Science ®Google Scholar
• Wang C, Thor AD, Moore DH, Zhao Y, Kerschmann R, Stern R, Watson PH, Turley EA. The over expression of RHAMM, a hyaluronan-binding protein that regulates ras signalling, correlates with over-expression of mitogen-activated protein kinase and is a significant parameter in breast cancer progression. Clin Cancer Res 1998; 4: 567–576
   PubMed Web of Science ®Google Scholar
• Yadav AK, Mishra P, Mishra AK, Mishra P, Jain S, Agrawal GP. Development and characterization of hyaluronic acid–anchored PLGA nanoparticulate carriers of doxorubicin. Nanomedicine: Nanotechnol Biol Med 2007; 3: 246–257
   PubMed Web of Science ®Google Scholar
• Zalipsky S, Gilon C, Zilkha A. Attachment of drugs to polyethylene glycols. Eur Polym J 1983; 19: 1177–1183
   Web of Science ®Google Scholar